vs

Side-by-side financial comparison of BayCom Corp (BCML) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $13.2M, roughly 2.0× TriSalus Life Sciences, Inc.). BayCom Corp runs the higher net margin — 26.5% vs -73.9%, a 100.3% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

BCML vs TLSI — Head-to-Head

Bigger by revenue
BCML
BCML
2.0× larger
BCML
$25.9M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+50.4% gap
TLSI
59.8%
9.4%
BCML
Higher net margin
BCML
BCML
100.3% more per $
BCML
26.5%
-73.9%
TLSI
More free cash flow
BCML
BCML
$32.6M more FCF
BCML
$30.1M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
TLSI
TLSI
Revenue
$25.9M
$13.2M
Net Profit
$6.9M
$-9.8M
Gross Margin
86.7%
Operating Margin
36.6%
-24.8%
Net Margin
26.5%
-73.9%
Revenue YoY
9.4%
59.8%
Net Profit YoY
12.1%
3.5%
EPS (diluted)
$0.63
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
TLSI
TLSI
Q4 25
$25.9M
$13.2M
Q3 25
$25.7M
$11.6M
Q2 25
$24.7M
$11.2M
Q1 25
$24.3M
$9.2M
Q4 24
$23.7M
$8.3M
Q3 24
$25.6M
$7.3M
Q2 24
$23.8M
$7.4M
Q1 24
$24.5M
$6.5M
Net Profit
BCML
BCML
TLSI
TLSI
Q4 25
$6.9M
$-9.8M
Q3 25
$5.0M
$-10.8M
Q2 25
$6.4M
$-8.3M
Q1 25
$5.7M
$-10.4M
Q4 24
$6.1M
$-10.1M
Q3 24
$6.0M
$-2.4M
Q2 24
$5.6M
$-4.3M
Q1 24
$5.9M
$-13.2M
Gross Margin
BCML
BCML
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
BCML
BCML
TLSI
TLSI
Q4 25
36.6%
-24.8%
Q3 25
26.3%
-77.9%
Q2 25
35.3%
-65.4%
Q1 25
31.6%
-79.9%
Q4 24
34.2%
-91.8%
Q3 24
32.4%
-118.9%
Q2 24
31.9%
-111.0%
Q1 24
33.3%
-180.8%
Net Margin
BCML
BCML
TLSI
TLSI
Q4 25
26.5%
-73.9%
Q3 25
19.5%
-93.5%
Q2 25
25.8%
-73.9%
Q1 25
23.4%
-113.2%
Q4 24
25.9%
-122.4%
Q3 24
23.5%
-32.6%
Q2 24
23.6%
-58.8%
Q1 24
24.0%
-204.5%
EPS (diluted)
BCML
BCML
TLSI
TLSI
Q4 25
$0.63
$-0.22
Q3 25
$0.46
$-0.96
Q2 25
$0.58
$-0.27
Q1 25
$0.51
$-0.39
Q4 24
$0.55
$-0.38
Q3 24
$0.54
$-0.12
Q2 24
$0.50
$-0.21
Q1 24
$0.51
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.6M
$-33.9M
Total Assets
$2.6B
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
TLSI
TLSI
Q4 25
$20.4M
Q3 25
$22.7M
Q2 25
$26.5M
Q1 25
$13.0M
Q4 24
$8.5M
Q3 24
$11.3M
Q2 24
$16.5M
Q1 24
$4.0M
Stockholders' Equity
BCML
BCML
TLSI
TLSI
Q4 25
$338.6M
$-33.9M
Q3 25
$334.3M
$-26.7M
Q2 25
$330.6M
$-19.4M
Q1 25
$329.3M
$-34.4M
Q4 24
$324.4M
$-25.9M
Q3 24
$321.7M
$-20.4M
Q2 24
$315.3M
$-25.3M
Q1 24
$314.2M
$-36.0M
Total Assets
BCML
BCML
TLSI
TLSI
Q4 25
$2.6B
$35.3M
Q3 25
$2.6B
$36.5M
Q2 25
$2.6B
$41.3M
Q1 25
$2.6B
$28.6M
Q4 24
$2.7B
$24.0M
Q3 24
$2.6B
$27.5M
Q2 24
$2.6B
$32.4M
Q1 24
$2.6B
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
TLSI
TLSI
Operating Cash FlowLast quarter
$31.8M
$-2.5M
Free Cash FlowOCF − Capex
$30.1M
$-2.5M
FCF MarginFCF / Revenue
116.2%
-19.1%
Capex IntensityCapex / Revenue
6.7%
0.3%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
TLSI
TLSI
Q4 25
$31.8M
$-2.5M
Q3 25
$7.3M
$-3.7M
Q2 25
$6.4M
$-7.3M
Q1 25
$9.3M
$-4.5M
Q4 24
$30.4M
$-5.7M
Q3 24
$9.6M
$-10.8M
Q2 24
$7.7M
$-13.4M
Q1 24
$5.1M
$-10.9M
Free Cash Flow
BCML
BCML
TLSI
TLSI
Q4 25
$30.1M
$-2.5M
Q3 25
$6.2M
$-3.9M
Q2 25
$5.6M
$-7.4M
Q1 25
$9.1M
$-5.3M
Q4 24
$28.7M
$-5.8M
Q3 24
$9.4M
$-11.0M
Q2 24
$7.4M
$-13.5M
Q1 24
$3.9M
$-10.9M
FCF Margin
BCML
BCML
TLSI
TLSI
Q4 25
116.2%
-19.1%
Q3 25
24.3%
-33.9%
Q2 25
22.8%
-66.1%
Q1 25
37.6%
-57.3%
Q4 24
121.1%
-69.7%
Q3 24
36.6%
-149.9%
Q2 24
31.2%
-183.1%
Q1 24
16.1%
-169.3%
Capex Intensity
BCML
BCML
TLSI
TLSI
Q4 25
6.7%
0.3%
Q3 25
4.3%
1.9%
Q2 25
3.0%
0.8%
Q1 25
0.6%
8.2%
Q4 24
7.2%
0.6%
Q3 24
1.0%
2.3%
Q2 24
1.0%
0.8%
Q1 24
4.7%
1.0%
Cash Conversion
BCML
BCML
TLSI
TLSI
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons